| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $383K | +1537.7% |
| SG&A Expense | $335K | +146.3% |
| Operating Income | -$718K | -427.4% |
| Pre-tax Income | -$718K | -427.4% |
| Net Income | -$718K | -427.4% |
| EPS (Basic) | -$0.02 | -260.0% |
| EPS (Diluted) | -$0.02 | -260.0% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Current Assets | $199K | — |
| Total Assets | $199K | — |
| Current Liabilities | $12K | -65.0% |
| Total Liabilities | $12K | -65.0% |
| Stockholders' Equity | $188K | +666.3% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$561K | -541.7% |
| Investing Cash Flow | -$175K | — |
| Financing Cash Flow | $754K | +766.9% |